ArticleFrontiers in endocrinology2021

Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.

Won Euh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.